SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about outcome of board meeting

29 Oct 2021 Evaluate

Shilpa Medicare has informed that the Board of Directors of Shilpa Medicare at their meeting held today i.e., 29 October 2021 resolved the following: Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the Second Quarter and Half Year ended 30 September 2021. The Copy of Financial Results and Limited Review Report is enclosed. The Board meeting commenced at 12:30 PM and concluded at 03: 00 PM.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×